A transgenic mouse model for human hereditary neuropathy with liability to pressure palsies

Molecular and Cellular Neurosciences

Volumn 8, Issue 6, 1997, Pages 405-416

  Maycox, Peter R ^a   Ortuño, Daniel ^a   Burrola, Patrick ^a   Kuhn, Rainer ^a   Bieri, Phyllis L ^b   Arrezo, Joseph C ^b   Lemke, Greg ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN PROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DISEASE ASSOCIATION; EVOKED SOMATOSENSORY RESPONSE; EVOKED VISUAL RESPONSE; GENE DOSAGE; GENE STRUCTURE; HOMOZYGOSITY; MORPHOLOGY; MOUSE; MYELIN SHEATH; NERVE CONDUCTION; NERVE PARALYSIS; NONHUMAN; PATHOGENESIS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SCIATIC NERVE;

ANIMALIA; MUS MUSCULUS;

EID: 0030440916     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1006/mcne.1997.0600     Document Type: Article

References (36)

1. Adlkofer K., Martini R., Aguzzi A., Zielasek J., Toyka K. V., Suter U. Hypermylenation and demyelinating peripheral neuropathy in Pmp-22 deficient mice. Nature Genet. 11:1995;274-280.
2. Chance P. F., Alderson M. K., Leppig K. A., Lensch M. W., Matsunami N. DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell. 72:1993;143-151.
3. Chomczynski P., Saachi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;67-77.
4. 0. Cell. 71:1992;565-576.
5. Griffiths I. R., Schneider A., Anderson J., Nave K. A. Transgenic and natural mouse models of proteolipid protein (PLP)-related dysmyelination and demyelination. Brain Pathol. 5:1995;275-281.
6. Krieg P. A., Melton D. A. In vitro RNA synthesis with SP6 RNA polymerase. Methods Enzymol. 155:1987;397-415.
7. Lemke G. Myelin and myelination. An Introduction to Molecular Neurobiology. 1992;Sinauer, Sunderland.
8. Lemke G., Axel R. Isolation and sequence of a cDNA encoding the major structural protein of peripheral myelin. Cell. 40:1985;501-508.
9. Lemke G., Lamar E., Patterson J. Isolation and analysis of the gene encoding peripheral myelin protein zero. Neuron. 1:1988;73-83.
10. Lupski J. R., de Oca-Luna L. M., Slaugenhaupt S., Pentao L., Guzetta V. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell. 66:1991;219-232.
11. Lupski J. R., Chance P. F., Garcia C. A. Inherited primary peripheral neuropathies: Molecular genetics and clinical implications of CMT1A and HNPP. J. Am. Med. Assoc. 270:1993;2326-2330.
12. Martini R., Zielasek J., Toyka K. V., Giese K. P., Schachner M. Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies. Nature Genet. 11:1995;281-286.
13. Matsunami N., Smith B., Ballard L., Lensch M. W., Robertson M. Peripheral myelin protein-22 gene maps in the duplication in chromosome 17p11.2 associated with Charcot-Marie-Tooth 1A. Nature Genet. 1:1992;176-179.
14. Meier C., Moll C. Hereditary neuropathy with liability to pressure palsies: Report of two families and review of the literature. J. Neurol. 228:1982;73-95.
15. Messing A., Behringer R. R., Hammang J. P., Pamiter R. D., Brinster R. L., Lemke G. Po promoter directs expression of reporter and toxin genes to Schwann cells of transgenic mice. Neuron. 8:1992;507-520.
16. Messing A., Behringer R. R., Wrabetz L., Hammang J. P., Lemke G., Palmiter R. D., Brinster R. L. Hypomyelinating peripheral neuropathies and schwannomas in transgenic mice expressing SV40 T-antigen. J. Neurosci. 14:1994;3533-3539.
17. Michaelson M., Bieri P., Mehler M., Xu H., Arezzo J., Pollard J., Kessler J. CSF-1 deficiency in mice results in abnormal brain development. Development. 122:1996;2661-2672.
18. Parmantier E., Cabon F., Braun C., D'Urso D., Muller H. W., Zalc B. Peripheral myelin protein-22 in rat and mouse brain and spinal cord motoneurons. Eur. J. Neurosci. 7:1995;1080-1088.
19. Patel P. I., Roa B. B., Welcher A. A., Schoerner-Scott R., Trask B. J. The gene for the peripheral myelin protein PMP-22 is a candidate for Charcot-Marie-Tooth disease type 1A. Nature Genet. 1:1992;159-165.
20. Reiter L. T., Murakami T., Koeuth T., Pentao L., Muzny D. M., Gibbs R. A., Lupski J. A recombination hotspot responsible for two inherited neuropathiesis located near a mariner transposon-like element. Nature Genet. 12:1996;288-297.
21. Roa B. B., Garcia C. A., Pentao L., Killian J. M., Trask B. J. Evidence for a recessive PMP22 point mutation in Charcot-Marie-Tooth disease type 1A. Nature Genet. 5:1993;189-194.
22. Scherer S. S., Chance P. F. Myelin genes: Getting the dosage right. Nature Genet. 11:1995;226-228.
23. Schneider C., King R. M., Philipson L. Genes specifically expressed at growth arrest of mammalian cells. Cell. 54:1988;787-792.
24. Sereda M., Griffiths I., Pühlhofer A., Stewart H., Rossner M. J., Zimmermamm F., Magyar J. P., Schneider A., Hund E., Meinck H.-M., Suter E., Nave K.-A. A transgenic rat model of Charcot-Marie-Tooth disease. Neuron. 16:1996;1049-1060.
25. Spreyer P., Kuhn G., Hanemann C. O., Gillen C., Schaal H., Kuhn R., Lemke G., Muller H. W. Axon-regulated expression of a Schwann cell transcript that is homologous to a "growth arrest-specific" gene. EMBO J. 10:1991;3661-3668.
26. Suter U., Moskow J. J., Welcher A. A., Snipes G. J., Kosaras D. A leucine-to-proline mutation in the putative first transmembrane domain of the 22-kDa peripheral myelin protein in the trembler-J mouse. Proc. Natl. Acad. Sci. USA. 89:1992a;4382-4386.
27. Suter U., Welcher A. A., Ozcelik T., Snipes G. J., Kosaras B. Trembler mouse carries a point mutation in a myelin gene. Nature. 356:1992b;241-244.
28. Suter U., Snipes G. J., Schoerner-Scott R., Welcher A. A., Pareek S. Regulation of tissue-specific expression of alternative peripheral myelin protein-22 (PMP22) gene transcripts by two promoters. J. Biol. Chem. 269:1994;25795-25808.
29. Suter U., Snipes G. J. Hereditary peripheral neuropathies. Annu. Rev. Neurosci. 18:1995;45-75.
30. Timmerman V., Nelis E., Van Hul W., Nieuwenhuijsen B. W., Chen K. L. The peripheral myelin protein gene PMP-22 is contained within the Charcot-Marie-Tooth disease type 1A duplication. Nature Genet. 1:1992;171-175.
31. Uncini A., Di Guglielmo G., Di Muzio A., Gambi D., Sabatelli M. Differential electrophysiological features of neuropathies associated with 17p11.2 deletion and duplication. Muscle Nerve. 18:1995;628-635.
32. Valentijn L. J., Baas F., Wolterman R. A., Hoogendijk J. E., Bosch N. H. A. Identical point mutations of PMP-22 in Trembler-J mouse and Charcot-Marie-Tooth disease type 1A. Nature Genet. 2:1992;288-291.
33. Weinstein D. E., Burrola P. G., Lemke G. Premature schwann cell differentiation and hypermyelination in mice expressing a targeted antagonist of the POU transcription factor SCIP. Mol. Cell. Neurosci. 6:1995;212-229.
34. Welcher A. A., Suter U., De Leon M., Snipes G. J., Shooter E. M. A myelin protein is encoded by the homologue of a growth arrest-specific gene. Proc. Natl. Acad. Sci. USA. 88:1991;7195-7199.
35. Wise C. A., Garcia C. A., Davis S. N., Heju Z., Pentao L. Molecular analysis of unrelated Charcot-Marie-Tooth (CMT) disease patients suggest a high frequency of the CMT1A duplication. Am. J. Hum. Genet. 53:1993;853-863.
36. You K-H., Hsieh C-L., Hayes C., Stahl H., Francke U., Popko B. DNA sequence, genomic organisation, and chromosomal localisation of the mouse peripheral myelin protein zero gene: Identification of polymorphic alleles. Genomics. 9:1991;751-757.